1 Min Read
May 17 (Reuters) - Dr.Reddy’s Laboratories Ltd
* Announces USFDA approval for launch of doxorubicin hydrochloride liposome injection in U.S. Market Source text - (bit.ly/2qQ6RC6) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.